Fertility and Sterility
Volume 94, Issue 2 , Pages 408-430 , July 2010

Technology requirements for preimplantation genetic diagnosis to improve assisted reproduction outcomes

  • Santiago Munné, Ph.D.

      Affiliations

    • Reprogenetics, Livingston, New Jersey
    • Corresponding Author InformationReprint requests: Santiago Munné, Ph.D., 3 Regent Street, Suite 301, Livingston, NJ 07039 (FAX: 973-243-6235).
    • ,
  • Dagan Wells, Ph.D.

      Affiliations

    • Reprogenetics UK Ltd., Oxford, United Kingdom
    • Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, United Kingdom
    • ,
  • Jacques Cohen, Ph.D.

      Affiliations

    • Reprogenetics, Livingston, New Jersey

Received 16 December 2008 ,Revised 23 February 2009 ,Accepted 26 February 2009.

References 

  1. Munné S. Preimplantation genetic diagnosis for infertility (PGD). In:  Harper J editors. Current status of preimplantation genetic diagnosis (PGD). Cambridge, UK: Cambridge University Press; 2008;Chapter 14
  2. Munné S. Improving pregnancy outcome for IVF patients with preimplantation genetic screening. Expert Rev Obstet Gynecol. 2008;3:635–646
  3. Hardarson T, Hanson C, Lundin K, Hillensjo T, Nilsson L, Stevic J, et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Hum Reprod. 2008;23:2806–2812
  4. Jansen RPS, Bowman MC, De Boer KA, Leigh DA, Lieberman DB, McArthur SJ. What next for preimplantation genetic screening (PGD)? Experience with blastocyst biopsy and testing for aneuploidy. Hum Reprod. 2008;23:1476–1478
  5. Mersereau JE, Pergament E, Zhang X, Milad MP. Preimplantation genetic screening to improve in vitro fertilization pregnancy rates: a prospective randomized controlled trial. Fertil Steril. 2008;90:1287–1289
  6. Simpson JL. The randomized clinical trial in assessing preimplantation genetic screening (PGD): necessary but not sufficient. Hum Reprod. 2008;23:2179–2181
  7. Yakin K, Urman B. What next for preimplantation genetic screening? A clinician's perspective. Hum Reprod. 2008;23:1686–1690
  8. Gleicher N, Weghofer A, Barad D. Preimplantation genetic screening: “established” and ready for prime time?. Fertil Steril. 2008;89:780–788
  9. Harper J, Sermon K, Geraedts J, Vesela K, Harton G, Thornhill A, et al. What next for preimplantation genetic screening?. Hum Reprod. 2008;23:478–480
  10. Garrisi JG, Colls P, Ferry KM, Zheng X, Garrisi MG, Munné S. Effect of infertility, maternal age, and number of previous miscarriages on the outcome of preimplantation genetic diagnosis for idiopathic recurrent pregnancy loss. Fertil Steril. Published online August 8, 2008.
  11. Jones GM, Cram DS, Song B, Kokkali G, Pantos K, Trounson AO. Novel strategy with potential to identify developmentally. Hum Reprod. 2008;23:1748–1759
  12. Wells D, Fragouli E, Stevens J, Munné S, Schoolcraft WB, Katz-Jaffe MG. High pregnancy rate after comprehensive chromosomal screening of blastocysts. [abstract] Fertil Steril. 2008;90(Suppl 1):S80
  13. Navot D, Bergh PA, Williams MA, Garrisi GJ, Guzman I, Sandler B, et al. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet. 1991;337:1375–1377
  14. Dailey T, Dale B, Cohen J, Munné S. Association between non-disjunction and maternal age in meiosis-II human oocytes detected by FISH analysis. Am J Hum Genet. 1996;59:176–184
  15. Hassold T, Jacobs PA, Kline J, Stein Z, Warburton D. Effect of maternal age on autosomal trisomies. Ann Hum Genet. 1980;44:29–36
  16. Munné S, Lee A, Rosenwaks Z, Grifo J, Cohen J. Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum Reprod. 1993;8:2185–2191
  17. Colls P, Escudero T, Zheng X, Lenzi M, Cinnioglu C, Cohen J, et al. Increased efficiency of preimplantation genetic diagnosis for infertility through reanalysis of dubious signals. Fertil Steril. 2007;88:53–61
  18. Gianaroli L, Magli C, Ferraretti AP, Munné S. Preimplantation diagnosis for aneuploidies in patients undergoing in-vitro fertilization with a poor prognosis: identification of the categories for which it should be proposed. Fertil Steril. 1999;72:837–844
  19. Munné S, Magli C, Cohen J, Morton P, Sadowy S, Gianaroli L, et al. Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. Hum Reprod. 1999;14:2191–2199
  20. Munné S, Sandalinas M, Escudero T, Velilla E, Walmsley R, Sadowy S, et al. Improved implantation after preimplantation genetic diagnosis of aneuploidy. Reprod Biomed Online. 2003;7:91–97
  21. Munné S, Fischer J, Warner A, Chen S, Zouves C, Cohen J. Referring Centers PGD Group. Preimplantation genetic diagnosis significantly reduces pregnancy loss in infertile couples: a multi-center study. Fertil Steril. 2006;85:326–332
  22. Munné S, Chen S, Fischer J, Colls P, Zheng X, Stevens J, et al. Preimplantation genetic diagnosis reduces pregnancy loss in women 35 and older with a history of recurrent miscarriages. Fertil Steril. 2005;84:331–335
  23. Munné S, Alikani M, Tomkin G, Grifo J, Cohen J. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertil Steril. 1995;64:382–391
  24. Munné S, Serena C, Colls P, Garrisi J, Zheng X, Cekleniak N, et al. Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos. Reprod Biomed Online. 2007;14:628–634
  25. Delhanty JDA, Harper JC, Ao A, Handyside AH, Winston RML. Multicolour FISH detects frequent chromosomal mosaicism and chaotic division in normal preimplantation embryos from fertile patients. Hum Genet. 1997;99:755–760
  26. Márquez C, Sandalinas M, Bahçe M, Alikani M, Munné S. Chromosome abnormalities in 1255 cleavage-stage human embryos. Reprod Biomed Online. 2000;1:17–27
  27. Kuliev A, Cieslak J, Ilkevitch Y, Verlinsky Y. Chromosomal abnormalities in a series of 6733 human oocytes in preimplantation diagnosis for age-related aneuploidies. Reprod Biomed Online. 2002;6:54–59
  28. Verlinsky Y, Cieslak V, Ivakhnenko S, Evsikov G, Wolf M, White M, et al. Chromosomal abnormalities in the first and second polar body. Mol Cell Endocrinol. 2001;183:S47–S49
  29. Bielanska M, Tan SL, Ao A. Chromosomal mosaicism throughout human preimplantation development in-vitro: incidence, type, and relevance to embryo outcome. Hum Reprod. 2002;17:413–419
  30. Magli MC, Gianaroli L, Ferrareti AP. Chromosomal abnormalities in embryos. Mol Cell Endocrinol. 2001;22, 183(Suppl 1):S29–34
  31. Magli MC, Gianaroli L, Ferrareti AP, Lappi M, Ruberti A, Farfalli V. Embryo morphology and development are dependent on the chromosome complement. Fertil Steril. 2007;87:534–541
  32. Alikani M, Calderon G, Tomkin G, Garrisi J, Kokot M, Cohen J. Cleavage anomalies in human embryos and survival after prolonged culture in-vitro. Human Reprod. 2000;15:2634–2643
  33. Sandalinas M, Sadowy S, Alikani M, Calderon G, Cohen J, Munné S. Developmental ability of chromosomally abnormal human embryos to develop to the blastocyst stage. Hum Reprod. 2001;16:1954–1958
  34. Magli MC, Jones GM, Gras L, Gianaroli L, Korman I, Trounson AO. Chromosome mosaicism in day 3 aneuploid embryos that develop to morphologically normal blastocysts in-vitro. Hum Reprod. 2000;15:1781–1786
  35. Li M, Marin DeUgarte C, Surrey M, Danzer H, DeCherney A, Hill DL. Fluorescence in-situ hybridization reanalysis of day-6 human blastocysts diagnosed with aneuploidy on day 3. Fertil Steril. 2005;84:1395–1400
  36. Verlinsky Y, Cieslak J, Frieidine M, Ivakhnenko V, Wolf G, Kovalinskaya L, et al. Pregnancies following pre-conception diagnosis of common aneuploidies by fluorescence in-situ hybridization. Hum Reprod. 1995;10:1923–1927
  37. Verlinsky Y, Cieslak J, Ivakhnenko V, Lifchez A, Strom C, Kuliev A. Preimplantation genetic group. Birth of healthy children after preimplantation diagnosis of common aneuploidies by polar body fluorescent in-situ hybridization analysis. Fertil Steril. 1996;66:126–129
  38. Munné S, Dailey T, Sultan KM, Grifo J, Cohen J. The use of first polar bodies for preimplantation diagnosis of aneuploidy. Hum Reprod. 1995;10:1015–1021
  39. Harper JC, de Die-Smulders C, Goossens V, Harton G, Moutou C, Repping S, et al. ESHRE PGD Consortium data collection VII: cycles from January to December 2004 with pregnancy follow-up to October 2005. Hum Reprod. 2008;23:2629–2645
  40. Magli MC, Gianaroli L, Ferraretti AP, Toschi M, Esposito F, Fasolino MC. The combination of polar body and embryo biopsy does not affect embryo viability. Hum Reprod. 2004;19:1163–1169
  41. Cieslak-Janzen J, Tur-Kaspa I, Ilkevitch Y, Bernal A, Morris R, Verlinsky Y. Multiple micromanipulations for preimplantation genetic diagnosis do not affect embryo development to the blastocyst stage. Fertil Steril. 2006;85:1826–1829
  42. Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M, et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod. 2004;19:2849–2858
  43. De Boer KA, Catt JW, Jansen RPS, Leigh D, McArthur S. Moving to blastocyst biopsy for preimplantation genetic diagnosis and single embryo transfer at Sydney IVF. Fertil Steril. 2004;82:295–298
  44. Hardy K, Martin KL, Leese HJ, Winston RML, Handyside AH. Human preimplantation development in-vitro is not adversely affected by biopsy at the 8-cell stage. Hum Reprod. 1990;5:708–714
  45. Cohen J, Wells D, Munné S. Removal of two cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests employed to enhance implantation rates. Fertil Steril. 2007;87:496–503
  46. Mastenbroek S, Twisk M, Van Echten-arends J, Sikkema-Raddatz B, Korevaar JC, Verhoeve HR, et al. Preimplantation genetic screening in women of advanced maternal age. N Engl J Med. 2007;357:9–17
  47. Munné S, Gianaroli L, Tur-Kaspa I, Magli C, Sandalinas M, Grifo J, et al. Sub-standard application of PGD may interfere with its clinical success. Fertil Steril. 2007;88:781–784
  48. Cohen J, Grifo J. Multicenter trial of preimplantation genetic screening reported in the New England Journal of Medicine: an in-depth look at the findings. Reprod Biomed Online. 2007;15:365–366
  49. Kuliev A, Verlinsky Y. Impact of preimplantation genetic diagnosis for chromosomal disorders on reproductive outcome. Reprod Biomed Online. 2007;16:9–10
  50. McArthur SJ, Leigh D, Marshall JT, Gee AJ, de Boer KA, Jansen RPS. Blastocyst trophectoderm biopsy and preimplantation genetic diagnosis for familial monogenic disorders and chromosomal translocations. Prenat Diagn. 2008;28:434–442
  51. Wilton LJ, Shaw JM, Trounson AO. Successful single-cell biopsy and cryopreservation of preimplantational mouse embryos. Fertil Steril. 1989;51:513–517
  52. Gordon JW, Talansky BE. Assisted fertilization by zona drilling: a mouse model for correction of oligospermia. J Exp Zool. 1986;239:347–354
  53. Germond M, Nocera D, Senn A, Rink K, Delacrétaz , Fakan S. Microdissection of mouse and human zona pellucida using a 1.48-microns diode laser beam: efficacy and safety of the procedure. Fertil Steril. 1995;64:604–611
  54. Chatzimeletiou K, Morrison E, Panagiotidis Y, Prapas N, Prapas Y, Rutherford AJ, et al. Comparison of the effects of zona drilling by non-contact infrared laser or acid Tyrode's on the development of human biopsied embryos as revealed by blastomere viability, cytoskeletal analysis and molecular cytogenetics. Reprod Biol Online. 2005;11:697–710
  55. Joris H, De Vos A, Janssens R, Devroey P, Liebaers L, Van Steirteghem A. Comparison of the results of human embryo biopsy and outcome of PGD after zona drilling using acid tyrode medium or laser. Hum Reprod. 2003;18:1896–1902
  56. Roudebush W, Kim J, Minhas BS. The 8-cell pre-embryo is the ideal stage for biopsy in the mouse. J In. Vitro Fertil Embryo Transf. 1990;7(4):32
  57. Gordon JW, Gang I. Use of zona drilling for safe and effective biopsy of murine oocytes and embryos. Biol Reprod. 1990;42:869–876
  58. Nikas G, Ao A, Winston RM, Handyside AH. Compaction and surface polarity in the human embryo in vitro. Biol Reprod. 1996;55:32–37
  59. Gualtieri R, Santella L, Dale B. Tight junctions and cavitation in the human pre-embryo. Mol Reprod Dev. 1992;32:81–87
  60. Reeve WJ. The distribution of ingested horseradish peroxidase in the 16-cell mouse embryo. J Embryol Exp Morphol. 1981;66:191–207
  61. Santaló J, Veiga A, Calafell JM, Calderon G, Vidal F, Barri PN, et al. Evaluation of cytogenetic analysis for clinical preimplantation diagnosis. Fertil Steril. 1995;64:44–50
  62. Dumoulin JCM, Bras M, Coonen E, Dreesen J, Geraedts JPM, Evers JLH. Effect of Ca/Mg-free medium on the biopsy procedure for preimplantation genetic diagnosis and further development of human embryos. Hum Reprod. 1998;13:2880–2883
  63. Kahraman S, Bahce M, Samli H, Imirzahoglu N, Yakisn K, Cengiz G, et al. Healthy births and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation failure. Hum Reprod. 2000;15:2003–2007
  64. Hill D, Li M. Embryo biopsy medium and PGD pregnancy rates. Clin Embryol. 2004;7:11–12
  65. In:  Verlinsky Y,  Kuliev A editor. An atlas of preimplantation genetic diagnosis: an illustrated textbook and reference for clinicians. 2nd ed. New York: Taylor & Francis; 2005;
  66. Tarkowski AK. An air drying method for chromosome preparations from mouse eggs. Cytogenetics. 1966;5:394–400
  67. Munné S, Márquez C, Reing A, Garrisi J, Alikani M. Chromosome abnormalities in embryos obtained following conventional IVF and ICSI. Fertil Steril. 1998;69:904–908
  68. Coonen E, Dumoulin JCM, Ramackers FCS, Hopman AHN. Optimal preparation of preimplantation embryo interphase nuclei for analysis by fluorescence in-situ hybridization. Hum Reprod. 1994;9:533–537
  69. Harper JC, Coonen E, Ramaekers FCS, Delhanty JDA, Handyside AH, Winston RML, et al. Identification of the sex of human preimplantation embryos in two hours using an improved spreading method and fluorescent in-situ hybridization (FISH) using directly labelled probes. Hum Reprod. 1994;9:721–724
  70. Dozortsev DI, McGinnis KT. An improved fixation technique for fluorescence in-situ hybridization for preimplantation genetic diagnosis. Fertil Steril. 2001;76:186–188
  71. Velilla E, Escudero T, Munné S. Blastomere fixation techniques and risk of misdiagnosis for PGD of aneuploidy. Reprod Biomed Online. 2002;4:210–217
  72. Xu K, Huang T, Tiezheng L, Zhongmig S, Rosenwaks Z. Improve the fixation method for preimplantation genetic diagnosis for fluorescent in-situ hybridization. J Assisted Reprod Genet. 1998;13:570–574
  73. Munné S, Bahçe M, Sandalinas M, Escudero T, Márquez C, Velilla E, et al. Differences in chromosome susceptibility to aneuploidy and survival to first trimester. Reprod Biomed Online. 2004;8:81–90
  74. Jobanputra V, Sobrino A, Kinney A, Kline J, Warburton D. Multiplex interphase FISH as a screen for common aneuploidies in spontaneous abortions. Hum Reprod. 2002;17:1166–1170
  75. Lathi RB, Westphal LM, Milki AA. Aneuploidy in the miscarriages of infertile women and the potential benefit of preimplantation genetic diagnosis. Fertil Steril. 2007;89:353–357
  76. Gutiérrez-Mateo C, Benet J, Wells D, Colls P, Bermúdez MG, Sánchez-García JF, et al. Aneuploidy study of human oocytes first polar body comparative genomic hybridization and metaphase II fluorescence in-situ hybridization analysis. Hum Reprod. 2004;19:2859–2868
  77. Gutiérrez-Mateo C, Wells D, Benet J, Sánchez-García JF, Bermúdez MG, Belil I, et al. Reliability of comparative genomic hybridization to detect chromosome abnormalities in first polar bodies and metaphase II oocytes. Hum Reprod. 2004;19:2118–2125
  78. Fragouli E, Wells D, Thornhill A, Serhal P, Faed MJ, Harper JC, et al. Comparative genomic hybridization analysis of human oocytes and polar bodies. Hum Reprod. 2006;21:2319–2328
  79. Voullaire L, Slater H, Williamson R, Wilton L. Chromosome analysis of blastomeres from human embryos by using comparative genomic hybridization. Hum Genet. 2000;106:210–217
  80. Wilton L, Williamson R, McBain J, Edgar D, Voullaire L. Birth of a healthy infant after preimplantation confirmation of euploidy by comparative genomic hybridization. N Engl J Med. 2001;345:1537–1541
  81. Wilton L, Voullaire L, Sargeant P, Williamson R, McBain J. Preimplantation aneuploidy screening using comparative genomic hybridization or fluorescence in-situ hybridization of embryos from patients with recurrent implantation failure. Fertil Steril. 2003;80:860–868
  82. Wells D, Escudero T, Levy B, Hirschhorn K, Delhanty JDA, Munné S. First clinical application of comparative genome hybridization and polar body testing for preimplantation genetic diagnosis of aneuploidy. Fertil Steril. 2002;78:543–549
  83. Sher G, Keskintepe L, Keskintepe M, Ginsburg M, Maassarani G, Yakut T, et al. Oocyte karyotyping by comparative genome hybridization provides a highly reliable method for selecting “competent” embryos, markedly improving in-vitro fertilization outcome: a multiphase study. Fertil Steril. 2007;87:1033–1040
  84. Voullaire L, Collins V, Callaghan T, McBain J, Williamson R, Wilton L. High incidence of complex chromosome abnormality in cleavage embryos from patients with repeated implantation failure. Fertil Steril. 2007;87:1053–1058
  85. Gianaroli L, Magli C, Ferraretti AP, Tabanelli C, Trengia V, Farfalli V, et al. The beneficial effects of PGD for aneuploidy support extensive clinical application. Reprod Biomed Online. 2004;10:633–640
  86. Munné S, Weier U. Simultaneous enumeration of chromosomes 13, 18, 21, X and Y in interphase cells for preimplantation genetic diagnosis of aneuploidy. Cytogenet Cell Genet. 1996;75:263–270
  87. Magli MC, Sandalinas M, Escudero T, Morrison L, Ferrareti AP, Gianaroli L, et al. Double locus analysis of chromosome 21 for preimplantation genetic diagnosis of aneuploidy. Prenat Diagn. 2001;21:1080–1085
  88. Colls P, Sandalinas M, Pagidas K, Munné S. PGD analysis for aneuploidy in a patient heterozygous for a polymorphism of chromosome 16 (16qh-). Prenat Diagn. 2004;24:741–744
  89. Coulam CB, Jeyendram RS, Fiddler M, Pergament E. Discordance among blastomeres renders preimplantation genetic diagnosis for aneuploidy ineffective. J Assist Reprod Genet. 2007;24:37–41
  90. Munné S, Magli C, Adler A, Wright G, de Boer K, Mortimer D, et al. Treatment-related chromosome abnormalities in human embryos. Hum Reprod. 1997;12:780–784
  91. Delhanty JD, Griffin DK, Handyside AH, Harper J, Atkinson GH, Pieters MH, et al. Detection of aneuploidy and chromosomal mosaicism in human embryos during preimplantation sex determination by fluorescent in-situ hybridization (FISH). Hum Mol Genet. 1993;2:1183–1185
  92. Munné S, Sandalinas M, Escudero T, Márquez C, Cohen J. Chromosome mosaicism in cleavage stage human embryos: evidence of a maternal age effect. Reprod Biomed Online. 2002;4:223–232
  93. Baart E, Van Opstal D, Los FJ, Fauser BC, Martini E. Fluorescence in-situ hybridization analysis of two blastomeres from day-3 frozen-thawed embryos followed by analysis of the remaining embryo on day-5. Hum Reprod. 2004;19:685–693
  94. Preimplantation Genetic Diagnosis International Society (PGDIS) . Guidelines for good practice in PGD: programme requirements and laboratory quality assurance. Reprod Biomed Online. 2007;16:134–147
  95. Munné S, Márquez C, Magli C, Morton P. Morrison. Scoring criteria for preimplantation genetic diagnosis of numerical abnormalities for chromosomes X, Y, 13, 16, 18 and 21. Mol Hum Reprod. 1998;4:863–870
  96. Eiben B, Goebel R, Hansen S, Hammans W. Early amniocentesis. A cytogenetic evaluation of over 1500 cases. Prenat Diagn. 1994;14:497–501
  97. Verlinsky Y, Tur-Kaspa I, Cieslak J, Bernal A, Morris R, Taranissi M, et al. Preimplantation testing for chromosomal disorders improves reproductive outcome of poor-prognosis patients. Reprod Biomed Online. 2005;11:219–225
  98. Twisk M, Haadsma ML, Van der Veen F, Repping S, Mastenbroek S, Heineman MJ, et al. Preimplantation genetic screening as an alternative to prenatal testing for Down syndrome: preferences of women undergoing in-vitro fertilization/intracytoplasmic sperm injection treatment. Fertil Steril. 2007;88:804–810
  99. Regan L, Braude PR, Trembath PL. Influence of past reproductive performance on risk of spontaneous abortion. BMJ. 1989;299:541–545
  100. Fretts RC, Schmittdiel J, McLean FH, Usher RH, Goldman MB. Increased maternal age and the risk of fetal death. N Engl J Med. 1995;333:953–957
  101. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320:1708–1712
  102. La Rochebrochard E, Thonneau P. Paternal age and maternal age are risk factors for miscarriage: results of a multi-centre European study. Hum Reprod. 2000;17:1649–1656
  103. Kupka MS, Dorn C, Montag M, Felberbaum RE, Van der Ven H, Kulczycki A, et al. Previous miscarriages influence IVF and intracytoplasmic sperm injection pregnancy outcome. Reprod Biomed Online. 2004;8:349–357
  104. Society for Assisted Reproductive Technology. SART CORS Online. All SART Member Clinics: Clinic Summary Report. Accessed March 5, 2009. Available at: https://www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?ClinicPKID=0.
  105. Spandorfer SD, Davis OK, Barmat LI, Chung PH, Rosenwaks Z. Relationship between maternal age and aneuploidy in in-vitro fertilization pregnancy loss. Fertil Steril. 2004;81:1265–1269
  106. Qumsiyeh MB, Kim KR, Ahmed MN, Bradford W. Cytogenetics and mechanisms of spontaneous abortions: increased apoptosis and decreased cell proliferation in chromosomally abnormal villi. Cytogenet Cell Genet. 2000;88:230–235
  107. Gianaroli L, Magli MC, Ferraretti AP. The in-vivo and in-vitro efficiency and efficacy of PGD for aneuploidy. Mol Cell Endocrinol. 2001;183:S13–S18
  108. Gianaroli L, Magli MC, Ferraretti AP, Tabanelli C, Trombetta C, Boudjema E. The role of preimplantation diagnosis for aneuploidy. Reprod Biomed Online. 2001;4:31–36
  109. Munné S, Garrisi J, Barnes F, Werlin L, Schoolcraft W, Kaplan B. Reduced spontaneous abortion and increased live birth rate after PGD for advanced maternal age. Fertil Steril. 2007;88(Suppl 1):S85–S86
  110. Crosignani PC, Rubin BL. Recurrent spontaneous miscarriage. The recommendations of the ESHRE workshop on recurrent spontaneous miscarriages held in Anacapri on September 9–11, 1990. Hum Reprod 1991;6:609–10.
  111. Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril. 1996;66:24–29
  112. American Society for Reproductive Medicine Practice Committee. Definitions of infertility and recurrent pregnancy loss. Fertil Steril. 2008;89:1603
  113. Simpson JL. Incidence and timing of pregnancy losses: relevance to evaluating safety of early prenatal diagnosis. Am J Med Genet. 1990;35:165–173
  114. Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod. 1994;9:1328–1332
  115. Quenby S, Vince G, Farquharson R, Aplin J. Recurrent miscarriage: a defect in nature's quality control?. Hum Reprod. 2002;17:1959–1963
  116. Jacobs PA, Hassold TJ. Chromosome abnormalities: origin and etiology in abortions and live births. In:  Vogal F,  Sperling K editor. Human genetics. Berlin: Springer-Verlag; 1987;p. 233–244
  117. McFadyen IR. Early fetal loss. In:  Rodeck C editors. Fetal medicine. Oxford: Blackwell Scientific; 1989;p. 26–43
  118. Bricker L, Farquharson RG. Types of pregnancy loss in recurrent miscarriage: implications for research and clinical practice. Hum Reprod. 2002;17:1345–1350
  119. Burgoyne PS, Holland K, Stephens R. Incidence of numerical chromosome abnormalities in human pregnancy estimated from induced and spontaneous abortion data. Hum Reprod. 1991;6:555–565
  120. Daniely M, Aviram-Goldring A, Barkai G, Goldman B. Detection of chromosomal aberrations in fetuses arising from recurrent spontaneous abortions by comparative genome hybridization. Hum Reprod. 1998;13:805–809
  121. Fritz B, Hallermann C, Olert J, Fucs B, Bruns M, Aslan M, et al. Cytogenetic analyses of culture failures by comparative genome hybridization. Re-evaluation of chromosome aberration rates in early spontaneous abortions. Eur J Hum Genet. 2001;9:539–547
  122. Stephenson MD, Awartani KA, Robinson WP. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. Hum Reprod. 2002;17:446–451
  123. Stern JJ, Dorfman AD, Gutierrez-Najar MD. Frequency of abnormal karyotype among abortuses from women with and without a history of recurrent spontaneous abortions. Fertil Steril. 1996;65:250–253
  124. Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril. 2000;73:300–304
  125. Vidal F, Gimenez C, Rubio C, Simon C, Pellicer Z, Santalo J, et al. FISH preimplantation diagnosis of chromosome aneuploidy in recurrent pregnancy wastage. J Assist Reprod Genet. 1998;15:310–313
  126. Simón C, Rubio C, Vidal F, Moreno C, Parrilla JJ, Pellicer A. Increased chromosome abnormalities in human preimplantation embryos after in-vitro fertilization in patients with recurrent miscarriages. Reprod Fertil Dev. 1998;10:987–992
  127. Pellicer A, Rubio C, Vidal F, Minguez Y, Gimenez C, Egozcue J, et al. In vitro fertilization plus preimplantation genetic diagnosis in patients with recurrent miscarriage: an analysis of chromosome abnormalities in human preimplantation embryos. Fertil Steril. 1999;71:1033–1039
  128. Rubio C, Simon C, Vidal F, Rodrigo L, Pehlivan T, Remohi J, et al. Chromosomal abnormalities and embryo development in recurrent miscarriage couples. Hum Reprod. 2003;18:182–188
  129. Munne S, Fischer J, Colls P, Escudero T, Zheng X. Preimplantation genetic screening for recurrent pregnancy loss. [abstract] Fertil Steril. 2008;90(Suppl 1):S24
  130. Rubio C, Buendía P, Rodrigo L, Mercader A, Mateu E, Peinado V, et al. Prognostic factors for preimplantation genetic screening in repeated pregnancy loss. Hum Reprod. 2009;18:687–693
  131. Werlin L, Rodi I, DeCherney A, Marello E, Hill D, Munné S. Preimplantation genetic diagnosis (PGD) as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertil Steril. 2003;80:467–468
  132. Brigham SA, Colon C, Farquharson RG. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod. 1999;14:2868–2871
  133. Munné S, Morrison L, Fung J, Márquez C, Weier U, Bahçe M, et al. Spontaneous abortions are reduced after preconception diagnosis of translocations. J Assist Reprod Genet. 1998;15:290–296
  134. Munné S, Sandalinas M, Escudero T, Fung J, Gianaroli L, Cohen J. Outcome of preimplantation genetic diagnosis of translocations. Fertil Steril. 2000;73:1209–1218
  135. Practice Committee of the Society for Assisted Reproductive Technology and the Practice Committee of the American Society for Reproductive Medicine. Preimplantation genetic testing: a practice committee opinion. Fertil Steril. 2007;88:1497–1504
  136. Sugiura-Ogasawara M, Ozaki Y, Sato T, Suzumori N, Suzumori K. Poor prognosis of recurrent aborters with either maternal or paternal reciprocal translocations. Fertil Steril. 2004;81:367–373
  137. Stephenson MD, Sierra S. Reproductive outcomes in recurrent pregnancy loss associated with a parental carrier of a structural chromosome rearrangement. Hum Reprod. 2006;21:1076–1082
  138. De Braekeleer M, Dao TN. Cytogenetic studies in couples experiencing repeated pregnancy losses. Hum Reprod. 1990;5:519–528
  139. Carp HJA, Dirnfeld M, Dor J, Grudzinskas JG. ART in recurrent miscarriage: Preimplantation genetic diagnosis/screening or surrogacy?. Hum Reprod. 2004;19:1502–1505
  140. Goddijn M, Joosten JH, Knegt AC, Van der Veen F, Franssen MTM, Bonsel GJ, et al. Clinical relevance of diagnosing structural chromosome abnormalities in couples with repeated miscarriage. Hum Reprod. 2004;19:1013–1017
  141. Fischer J, Colls P, Escudero T, Munne S. Preimplantation genetic diagnosis (PGD) improves pregnancy outcome for translocation carriers with a history of recurrent losses. Fertil Steril. 2010;94:283–289
  142. Verlinsky Y, Cieslak V, Evsikov G, Galat V, Kuliev A. Nuclear transfer for full karyotyping and preimplantation diagnosis for translocations. Reprod Biomed Online. 2002;5:300–305
  143. Munné S. Preimplantation genetic diagnosis for translocations. Hum Reprod. 2006;21:839–840
  144. Gianaroli L, Magli C, Fiorentino F, Baldi M, Ferraretti AP. Clinical value of preimplantation genetic diagnosis. Placenta. 2003;24:S77–S83
  145. Lim CK, Jum JH, Min DM, Lee HS, Kim JY, Koong MK, et al. Efficacy and clinical outcome of preimplantation genetic diagnosis using FISH for couples of reciprocal and Robertsonian translocations: the Korean experience. Prenat Diagn. 2004;24:556–561
  146. Otani T, Roche M, Mizuikea M, Colls P, Escudero T, Munné S. Preimplantation genetic diagnosis significantly improves the pregnancy outcome of translocation carriers with a history of recurrent miscarriage and failing to produce a live birth. Reprod Biomed Online. 2006;13:879–894
  147. Schoolcraft WB, Katz-Jaffe MG, Stevens J, Rawlins M, Munné S. Preimplantation genetic diagnosis for aneuploidy screening: a randomized prospective trial. Fertil Steril. 2008;Published online August 11, 2008 [Epub ahead of print]
  148. Platteau P, Staessen C, Michiels A, Van Steirteghem A, Liebaers I, Devroey P. Preimplantation genetic diagnosis for aneuploidy screening in patients with unexplained recurrent miscarriages. Fertil Steril. 2005;83:393–397
  149. Reis Soares S, Rubio C, Rodrigo L, Simon C, Remohi J, Pellicer A. High frequency of chromosomal abnormalities in embryos obtained from oocyte donation cycles. Fertil Steril. 2003;80:656–657
  150. Munné S. Chromosome abnormalities and their relationship to morphology and development of human embryos. Reprod Biomed Online. 2006;12:234–253
  151. Goossens V, De Rycke M, De Vos A, Staessen C, Michiels A, Verpoest W, et al. Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum Reprod. 2008;23:481–492
  152. Zosmer A, Epstein M, Al-Shawaf T. Ethical recruitment of patients for PGD trial. Hum Reprod. 2008;23:1472–1473
  153. Tur-Kaspa I. Optimizing ovarian stimulation and ET for IVF-PGD cycle. Post graduate course on PGD. The 63 annual meeting of the American Society for Reproductive Medicine, Washington DC, October 13–17, 2007.
  154. Munné S, Dailey T, Finkelstein M, Weier HU. Reduction in signal overlap results in increased FISH efficiency: implications for preimplantation genetic diagnosis. J Assist Reprod Genet. 1996;13:149–156
  155. Fragouli E, Lenzi M, Ross R, Katz-Jaffe M, Schoolcraft WB, Wells D. Comprehensive molecular cytogenetic analysis of the human blastocyst stage. Hum Reprod. 2008;23:2596–2608
  156. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative Genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992;258:818–821
  157. Wells D, Sherlock JK, Handyside AH, Delhanty DA. Detailed chromosomal and molecular genetic analysis of single cells by whole genome amplification and comparative genome hybridization. Nucleic Acid Res. 1999;27:1214–1218
  158. Voullaire L, Wilton L, Slater H, Williamson R. Detection of aneuploidy in single cells using comparative genome hybridization. Prenat Diagn. 1999;19:846–851
  159. Pinkel D, Landegent J, Collins C, Fuscoe J, Segraves R, Lucas J, et al. Fluorescence in-situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci USA. 1998;85:9138–9142
  160. Fragouli E, Wells D, Whalley KM, Mills JA, Faed MJ, Delhanty JD. Increased susceptibility to maternal aneuploidy demonstrated by comparative genomic hybridization analysis of human M-II oocytes and first polar bodies. Cytogenet Genome Res. 2006;114:30–38
  161. Wells D, Delhanty JDA. Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization. Mol Hum Reprod. 2000;6:1055–1062
  162. Munné S, Wells D. Questions concerning the suitability of comparative genome hybridization for preimplantation genetic diagnosis. Fertil Steril. 2003;80:871–872
  163. Verlinsky Y, Kuliev A. Preimplantation diagnosis for aneuploidies using fluorescence in-situ hybridization or comparative genomic hybridization. Fertil Steril. 2003;80:869–870
  164. Fragouli E, Delhanty JD, Wells D. Single cell diagnosis using comparative genomic hybridization after preliminary DNA amplification still needs more tweaking: too many miscalls. Fertil Steril. 2007;88:247–248
  165. Landwehr C, Montag M, Van der Ven K, Weber R. Rapid comparative genomic hybridization protocol for prenatal diagnosis and its application to aneuploidy screening of human polar bodies. Fertil Steril. 2008;90:488–496
  166. Stehlik E, Stehlik J, Katayama KP, Kuwayama M, Jambor V, Brohammer R, et al. Vitrification demonstrates significant improvement versus slow freezing of human blastocysts. Reprod Biomed Online. 2005;11:53–57
  167. Stachecki JJ, Garrisi J, Sabino S, Caetano JP, Wiemer KE, Cohen J. A new safe, simple and successful vitrification method for bovine and human blastocysts. Reprod Biomed Online. 2008;17:360–367
  168. Harper JC, Wells D. Recent advances and future developments in PGD. Prenat Diagn. 1990;19:1193–1199
  169. Weier HUG, Munné S, Lersch RA, Hsieh HB, Smida J, Chen XN, et al. Towards a full karyotype screening of interphase cells: ‘FISH and chip' technology. Mol Cell Endocrinol. 2001;183:S41–S45
  170. Kearns WG, Pen R, Benner A, Widra E, Leach R. Comprehensive genetic analyses using a modified whole genome amplification protocol and microarrays to identify genetic disorders and determine embryo implantation from single cells. Fertil Steril. 2007;88(Suppl 1):S236–S237
  171. Treff NR, Su J, Mavrianos J, Bergh PA, Miller KA, Scott RT. Accurate 23 chromosome aneuploidy screening in human blastomeres using single nucleotide polymorphism (SNP) microarrays. Fertil Steril. 2007;88(Suppl 1):S1
  172. Munné S, Steuerwald NM, Wells D, Bethea S, Nowak NJ, Cohen J. Comprehensive aneuploidy screening in single cells using microarray comparative genomic hybridization methods implications for preimplantation genetic diagnosis. Fertil Steril. 2007;88(Suppl 1):S86
  173. Scott RT, Miller KA, Olivares R, Su J, Fratterelli JL, Treff NR. Microarray based 24 chromosome preimplantation genetic diagnosis (mPGD) is highly predictive of the reproductive potential of human embryos: a prospective blinded non-selection trial. Fertil Steril. 2008;90(Suppl 1):S22–S23
  174. Wells D, Alfarawati S, Fragouli E. Use of comprehensive chromosomal screening for embryo assessment: microarrays and CGH. Mol Hum Reprod. 2008;14:703–710
  175. Elder K, Cohen J. Human preimplantation embryo selection. Boca Raton, FL: Taylor & Francis; 2007;
  176. Sugiura-Ogasawara M, Suzumori K. Can preimplantation genetic diagnosis improve success rates in recurrent aborters with translocations?. Hum Reprod. 2004;19:2171–2172

 S.M., D.W., and J.C. have a financial interest in Reprogenetics, which performs PGD.

 Partially funded by NIHR Biomedical Research Centre Programme (to D.W.).

PII: S0015-0282(09)00520-2

doi: 10.1016/j.fertnstert.2009.02.091

Fertility and Sterility
Volume 94, Issue 2 , Pages 408-430 , July 2010

Article Tools

* Image Usage & Resolution